The portable cancer screen devices market is projected to grow from USD 2.9 billion in 2025 to USD 11.9 billion by 2035, at a CAGR of 15.2%. Breast Cancer will dominate with a 47.6% market share, while fluorescence will lead the technology segment with a 42.8% share.